Nevoit Ganna, Jarusevicius Gediminas, Potyazhenko Maksim, Mintser Ozar, Bumblyte Inga Arune, Vainoras Alfonsas
Laboratory for Automatization of Cardiovascular Investigations, Cardiology Institute, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Department of Internal Medicine and Emergency Medicine, Poltava State Medical University, 36011 Poltava, Ukraine.
Biomedicines. 2025 Apr 15;13(4):963. doi: 10.3390/biomedicines13040963.
: This review has been prepared to promote interest in the interdisciplinary study of mitochondrial dysfunction (MD) and atherosclerosis. This review aims to describe the state of this problem and indicate the direction for further implementation of this knowledge in clinical medicine. : Extensive research of the literature was implemented to elucidate the role of the molecular mechanisms of MD in the pathogenesis of atherosclerosis. : A view on the pathogenesis of atherosclerosis through the prism of knowledge about MD is presented. MD is the cause and primary mechanism of the onset and progression of atherosclerosis. It is proposed that this problem be considered in the context of a continuum. : MD and atherosclerosis are united by common molecular mechanisms of pathogenesis. Knowledge of MD should be used to argue for a healthy lifestyle as the primary way to prevent atherosclerosis. The development of new approaches to diagnosing and treating MD in atherosclerosis is an urgent task and challenge for modern science.
本综述旨在激发人们对线粒体功能障碍(MD)与动脉粥样硬化跨学科研究的兴趣。本综述旨在描述该问题的现状,并指出将这些知识进一步应用于临床医学的方向。:对文献进行了广泛研究,以阐明MD分子机制在动脉粥样硬化发病机制中的作用。:通过MD相关知识的视角呈现了对动脉粥样硬化发病机制的看法。MD是动脉粥样硬化发生和发展的原因及主要机制。建议在连续统一体的背景下考虑这个问题。:MD和动脉粥样硬化通过共同的发病分子机制联系在一起。应利用对MD的了解来倡导健康的生活方式,将其作为预防动脉粥样硬化的主要途径。开发诊断和治疗动脉粥样硬化中MD的新方法是现代科学的一项紧迫任务和挑战。